Opsis Therapeutics
PrivateLast Round
Corporate Funding
May 17, 2021
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Opsis Therapeutics is a biotechnology company that develops cell replacement therapies for ocular diseases using induced pluripotent stem cell (iPSC) technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Opsis Therapeutics Comparables
Compare Opsis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Agnos Therapeutics | 93% | |
| Luxa Biotechnology | 88% | |
| Regenerative Patch Technologies | 86% |
Opsis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | May 17, 2021 | ||||
| Seed | Jul 31, 2016 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 66% MoM, reaching 3.2K.
- Jun 19, 2026
Monthly visitors grew 118% MoM, reaching 1.9K.
Opsis Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Opsis Therapeutics's valuation, stock price, and market status.
Is Opsis Therapeutics a public or private company?
Opsis Therapeutics is a private company.
What is the current stock price of Opsis Therapeutics?
Opsis Therapeutics is a private company with no public stock price. Caplight tracks Opsis Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Opsis Therapeutics worth (valuation)?
Valuation information for Opsis Therapeutics is not publicly available.
Can I buy Opsis Therapeutics stock?
Opsis Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Opsis Therapeutics's last funding round?
Opsis Therapeutics's most recent funding round was Corporate Funding on May 17, 2021.
Who are the main investors in Opsis Therapeutics?
Investor information for Opsis Therapeutics is not publicly disclosed.
Will Opsis Therapeutics IPO soon?
No public IPO plans have been announced for Opsis Therapeutics.
How can I track Opsis Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Opsis Therapeutics's secondary market activity and sign up for updates.